InvestorsObserver is giving Evofem Biosciences Inc (EVFM) an Analyst Rating Rank of 80, meaning EVFM is ranked higher by analysts than 80% of stocks. The average projection by analysts for EVFM is $15 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Evofem Biosciences Inc Stock Today?
Evofem Biosciences Inc (EVFM) stock is trading at $3.40 as of 10:11 AM on Wednesday, Jul 8, a gain of $0.23, or 7.25% from the previous closing price of $3.17. The stock has traded between $3.20 and $3.40 so far today. Volume today is below average. So far 518,096 shares have traded compared to average volume of 5,644,842 shares.
